
Flammer syndrome in multiple sclerosis: diagnostics, prediction, and personalization of treatments
Author(s) -
Cihat Uzunköprü,
Yeşim Beckmann
Publication year - 2019
Publication title -
the epma journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.177
H-Index - 34
eISSN - 1878-5085
pISSN - 1878-5077
DOI - 10.1007/s13167-019-00179-w
Subject(s) - medicine , headaches , tinnitus , multiple sclerosis , feeling , disease , signs and symptoms , nausea , quality of life (healthcare) , physical therapy , audiology , surgery , psychology , psychiatry , social psychology , nursing
Flammer syndrome (FS) occurs from well-described signs and symptoms. The syndrome itself is not a disease, but it may be a directive marker for advancing therapeutic approaches by predictive and preventive measures as well as for personalization of treatments. The syndrome is related to many diseases, but FS has been rarely studied in multiple sclerosis (MS). The study aimed to determine whether FS signs and symptoms occur more often in people with MS than in healthy controls, and in order to personalize the treatment, we investigated the possible effect of current therapies on FS signs and symptoms.